Italy: market share of antidiabetics 2016, by type
This statistic illustrates the market share of treatments to cure diabetes in Italy as of 2016, by type. According to data, insulins owned the largest portion of the market with a share of 48.4 percent, followed far behind by Dipeptidyl peptidase IV (DPP IV), which accounted for 19.9 percent of the market.